侯旭奔
开通时间:..
最后更新时间:..
点击次数:
所属单位:药学院
发表刊物:FRONT PHARMACOL
关键字:anticancer;CDK2 inhibitor;purine;structure-based drug design;triple-negative breast cancer
第一作者:梁翰之
论文编号:1539149221204123650
卷号:13
页面范围:864342
字数:20
是否译文:否
发表时间:2022-05-03
上一条:PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer
下一条:Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity